Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

15
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

21
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
21
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

21
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
21
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

29
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
29
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

28
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
28
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

17
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same author

"⅓ Yacoub" for correction of supravalvular aortic stenosis: valve-sparing root enlargement and ascending aorta replacement in an adult patient.

Multimedia manual of cardiothoracic surgery : MMCTS·2026
Same author

Mitral Valve Entrapment of Preshaped Guidewire During TAVI.

JACC. Case reports·2026
Same author

Aortic homografts for native and prosthetic aortic valve and root endocarditis: Results from the EUropean REgistry of Cryopreserved Aortic Homografts EURECAH.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Emergent simultaneous cesarean section and maternal cardiac surgery.

Heart & lung : the journal of critical care·2026
Same author

Post-cardiotomy ECMO configurations after mitral valve replacement: a case series and strategy development.

Perfusion·2026

Related Experiment Video

Updated: Aug 1, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K

Minimally invasive valve surgery: pushing boundaries over the eighty.

Cristina Barbero1, Dario Brenna1, Antonio Salsano2

  • 1Department of Cardiovascular and Thoracic Surgery, Città della Salute e della Scienza, University of Turin, Turin, Italy.

Journal of Geriatric Cardiology : JGC
|May 1, 2023
PubMed
Summary

Minimally invasive valve surgery is safe for octogenarians, with age alone not being a contraindication. Key predictors for mid-term mortality include advanced age and elevated creatinine levels.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.1K

Related Experiment Videos

Last Updated: Aug 1, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.1K

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Cardiology

Background:

  • Increasing prevalence of valve disease in elderly patients (over 80 years).
  • Growing application of minimally invasive techniques in complex and elderly patient populations.

Purpose of the Study:

  • To assess early mortality and major complications in octogenarians undergoing minimally invasive valve surgery.
  • To identify independent predictors of mid-term mortality in this patient group.

Main Methods:

  • Retrospective analysis of 130 octogenarian patients undergoing minimally invasive mitral and/or tricuspid valve surgery (2006-2020).
  • Evaluation of primary endpoint: predictors for mid-term mortality.
  • Secondary endpoints included operative mortality, stroke, early composite outcomes, and quality of life.

Main Results:

  • Operative mortality was 6%, with a 0.8% stroke rate.
  • One-year and five-year survival rates were 86% and 64%, respectively.
  • Age (≥ 84 years) and creatinine level (≥ 1.22 mg/dL) independently predicted mid-term mortality. Female gender and hypertension predicted early composite outcomes.

Conclusions:

  • Age should not be an absolute contraindication for minimally invasive valve surgery in octogenarians.
  • Identifying patients likely to benefit is crucial for optimizing outcomes and avoiding futile interventions.